Ibogaine and LSD Producer MindMed Applies for Nasdaq Up-Listing

New York-based MindMed has applied for a Nasdaq up-listing and is valued at $190 million.

Ibogaine and LSD Producer MindMed Applies for Nasdaq Up-Listing